Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D-Responsive Gene Expression Across Cells and Tissues: Study Summary

Previous related pageVitamin D-Responsive Gene Expression Across Cells and Tissues: Full Evidence ReviewNext related pageTissue-Specific Vitamin D Metabolism and Gene Responses: Study Summary
Study at a glance

What question did the studies ask?

Researchers asked how gene activity responds to vitamin D in different cells, tissues and time periods. RNA messages are copied from genes. Measuring RNA is different from measuring a protein or how well a tissue works.

What did the researchers find?

A laboratory model of human immune cells, grown from a blood cancer, showed dependence on the vitamin D receptor. Removing this protein prevented the detected response to calcitriol, the active vitamin D hormone, under those conditions. This does not establish that every vitamin D response works identically.

Human intestinal cells grown in the laboratory responded differently by gut region and by how developed the cells were. Another study showed that a gene-message increase could occur before a detectable protein increase. These experiments did not establish the proposed clinical benefits.

A study of 25 healthy adults found selected blood-cell changes one day after vitamin D3, without an inactive comparison group. A separate year-long trial assigned older adults by chance to vitamin D3 or an inactive comparison treatment. It did not find a clear whole-blood gene response under its analysis. The studies differed in population, exposure, timing and measurement.

What does this mean?

The responses differed between cell types and conditions. A changed gene message does not automatically mean better tissue function. Laboratory active-hormone treatment and oral vitamin D3 are different interventions, and these studies do not establish a personal dose.

Read the full article below ↓

Vitamin D-related gene responses differ between cells, tissues and sampling times. A change in a gene message does not automatically mean more protein or better tissue function. This summary compares laboratory experiments, a short human blood study and a longer randomized trial. For the detailed evidence, read Vitamin D-Responsive Gene Expression Across Cells and Tissues: Full Evidence Review.

What was measured?

RNA is a message copied from a gene. DNA carries genetic information. Researchers measured RNA, selected proteins and where regulatory proteins were attached to DNA. These are separate measurements. Vitamin D and Gene Expression explains gene activity. The vitamin D receptor is a protein responding to active vitamin D, introduced in Vitamin D Receptors and placed in its wider family in Vitamin D and Nuclear Receptors.

Most cell experiments used calcitriol, the active vitamin D hormone. The human studies used vitamin D3. Removing the receptor is another different intervention. These studies do not make laboratory hormone treatment, receptor loss and an oral supplement interchangeable.

What did the laboratory studies find?

A human immune-cell model grown from a blood cancer showed many RNA responses to calcitriol. Deleting the vitamin D receptor prevented responses meeting the study’s analysis criteria. This supports receptor dependence under those conditions, not the absence of every possible vitamin D effect in every tissue. The gene-message experiment compared one edited cell line with one control line. Each line was a group grown from the same original cell. [1]

Human intestinal cells grown in the laboratory responded differently by gut region and how developed the cells were. Nine people supplied the tissue; some supplied both regions. Only a small set of responses was shared across every condition. The study did not directly test the proposed effects on barrier function or wound recovery. [2]

A separate human colon-culture study linked selected responses with a DNA-sequence difference. A gene message could increase before a detectable protein increase. The experiments did not demonstrate better DNA repair or cancer prevention. Vitamin D and Epigenetic Regulation explains why DNA accessibility and gene activity also need separate measurements. [3]

Kidney and liver experiments showed different ways receptor-related signals can alter gene control. One tested direct binding between isolated protein parts; the other examined where proteins were attached to DNA and how responses changed in stimulated cells. The mechanisms were not identical. A receptor acting outside its usual DNA-binding route could still alter gene activity. Vitamin D and Transcription Factors introduces these gene-regulating partnerships. [4] [5]

What did the human studies find?

Twenty-five healthy adults aged 21 to 54 received a total 80,000 international units of vitamin D3 over one day, with blood cells sampled the next day. Selected RNA changes were detected, but there was no inactive comparison group. The study did not directly measure better immune-cell movement or resistance to infection. Related laboratory comparisons used cells from the same participant pool, rather than independent groups. [6]

BEST-D assigned 305 older adults by chance to daily vitamin D3 or an inactive comparison treatment for a year. Blood vitamin D levels rose with supplementation, but the controlled analysis did not find genes meeting its standard for a clear whole-blood change after accounting for many tests. This does not exclude earlier responses, rare cells or other tissues. The short and long studies differed in population, dose pattern, timing and measurement. [7]

An earlier eight-person study reported before-and-after changes, but all participants received vitamin D3 and the two dose groups did not clearly differ. It provides weaker evidence for attribution than a trial with an inactive comparison group. [8]

What does the comparison mean?

The evidence supports particular responses in particular settings. A pathway name inferred from gene messages is not a measurement of the proposed function. Vitamin D Status vs Vitamin D Effect explains why a vitamin D blood level is also different from its biological effect. These studies do not establish that the same genes change in every tissue or that changing RNA automatically improves health.

Scientific sources

[1] A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes. Warwick T, Schulz MH, Günther S, Gilsbach R, Neme A, Carlberg C, Brandes RP, Seuter S. Scientific reports. 2021;11(1):6518. DOI 10.1038/s41598-021-86032-5; PMID 33753848; PMCID PMC7985518.

[2] Analysis of 1,25-dihydroxyvitamin D genomic action in human enteroids and colonoids reveals multiple regulatory effects of vitamin D in human intestinal physiology. Criss ZK, Deans-Fielder K, Fleet JC, Christakos S, Shroyer N. Frontiers in endocrinology. 2025;16:1538463. DOI 10.3389/fendo.2025.1538463; PMID 40535337; PMCID PMC12173921.

[3] Genomic profiling of active vitamin D colonic responses in African: and European-Americans identifies an ancestry-related regulatory variant of POLB. Witonsky D, Laxman B, Usman H, Bielski MC, Lawrence KM, Kupfer SS. PLoS genetics. 2026;22(1):e1011983. DOI 10.1371/journal.pgen.1011983; PMID 41505470; PMCID PMC12810902.

[4] A nonclassical vitamin D receptor pathway suppresses renal fibrosis. Ito I, Waku T, Aoki M, Abe R, Nagai Y, Watanabe T, Nakajima Y, Ohkido I, Yokoyama K, Miyachi H, Shimizu T, Murayama A, Kishimoto H, Nagasawa K, Yanagisawa J. The Journal of clinical investigation. 2013;123(11):4579-4594. DOI 10.1172/jci67804; PMID 24135137; PMCID PMC3809783.

[5] A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, Leblanc M, Coulter S, He M, Scott C, Lau SL, Atkins AR, Barish GD, Gunton JE, Liddle C, Downes M, Evans RM. Cell. 2013;153(3):601-613. DOI 10.1016/j.cell.2013.03.028; PMID 23622244; PMCID PMC3673534.

[6] In vivo vitamin D targets reveal the upregulation of focal adhesion-related genes in primary immune cells of healthy individuals. Ghosh Dastidar R, Jaroslawska J, Malinen M, Tuomainen TP, Virtanen JK, Bendik I, Carlberg C. Scientific reports. 2024;14(1):17552. DOI 10.1038/s41598-024-68741-9; PMID 39080417; PMCID PMC11289414.

[7] Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial. Berlanga-Taylor AJ, Plant K, Dahl A, Lau E, Hill M, Sims D, Heger A, Emberson J, Armitage J, Clarke R, Knight JC. EBioMedicine. 2018;31:133-142. DOI 10.1016/j.ebiom.2018.04.010; PMID 29685792; PMCID PMC6013786.

[8] Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial. Hossein-nezhad A, Spira A, Holick MF. PloS one. 2013;8(3):e58725. DOI 10.1371/journal.pone.0058725; PMID 23527013; PMCID PMC3604145.

Related reading

Library

The ERRα-VDR axis promotes calcitriol degradation and estrogen signaling in breast cancer cells, while VDR‐CYP24A1‐ERRα overexpression correlates with poor prognosis in patients with basal‐like breast cancer

Besides estrogen receptor alpha (ERα), estrogen‐related receptor alpha (ERRα) has also been shown to interfere with the VDR pathway, but its role in the antitumor and transactivation activity of calcitriol is completely unknown in breast cancer (BC).

Original paper ↗Read more →

Original sources

Source

A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes

The transcription factor vitamin D receptor (VDR) is the high affinity nuclear target of the biologically active form of vitamin D3 (1,25(OH)2D3).

Publication details

[1] A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes. Warwick T, Schulz MH, Günther S, Gilsbach R, Neme A, Carlberg C, Brandes RP, Seuter S. Scientific reports. 2021;11(1):6518. DOI 10.1038/s41598-021-86032-5; PMID 33753848; PMCID PMC7985518.

Read more →
Source

Analysis of 1,25-dihydroxyvitamin D genomic action in human enteroids and colonoids reveals multiple regulatory effects of vitamin D in human intestinal physiology.

Published in Criss ZK, Deans-Fielder K, Fleet JC, Christakos S, Shroyer N. Frontiers in endocrinology (2025).

Publication details

[2] Analysis of 1,25-dihydroxyvitamin D genomic action in human enteroids and colonoids reveals multiple regulatory effects of vitamin D in human intestinal physiology. Criss ZK, Deans-Fielder K, Fleet JC, Christakos S, Shroyer N. Frontiers in endocrinology. 2025;16:1538463. DOI 10.3389/fendo.2025.1538463; PMID 40535337; PMCID PMC12173921.

Read more →
Source

Genomic profiling of active vitamin D colonic responses in African- and European-Americans identifies an ancestry-related regulatory variant of POLB

In our study, we aimed to understand how active vitamin D affects colon cells from people with African and European backgrounds.

Publication details

[3] Genomic profiling of active vitamin D colonic responses in African: and European-Americans identifies an ancestry-related regulatory variant of POLB. Witonsky D, Laxman B, Usman H, Bielski MC, Lawrence KM, Kupfer SS. PLoS genetics. 2026;22(1):e1011983. DOI 10.1371/journal.pgen.1011983; PMID 41505470; PMCID PMC12810902.

Read more →
Source

A nonclassical vitamin D receptor pathway suppresses renal fibrosis.

[4] A nonclassical vitamin D receptor pathway suppresses renal fibrosis.

Publication details

[4] A nonclassical vitamin D receptor pathway suppresses renal fibrosis. Ito I, Waku T, Aoki M, Abe R, Nagai Y, Watanabe T, Nakajima Y, Ohkido I, Yokoyama K, Miyachi H, Shimizu T, Murayama A, Kishimoto H, Nagasawa K, Yanagisawa J. The Journal of clinical investigation. 2013;123(11):4579-4594. DOI 10.1172/jci67804; PMID 24135137; PMCID PMC3809783.

Read more →
Source

A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.

[5] A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.

Publication details

[5] A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, Leblanc M, Coulter S, He M, Scott C, Lau SL, Atkins AR, Barish GD, Gunton JE, Liddle C, Downes M, Evans RM. Cell. 2013;153(3):601-613. DOI 10.1016/j.cell.2013.03.028; PMID 23622244; PMCID PMC3673534.

Read more →
Source

In vivo vitamin D targets reveal the upregulation of focal adhesion-related genes in primary immune cells of healthy individuals.

Published in Ghosh Dastidar R, Jaroslawska J, Malinen M, Tuomainen TP, Virtanen JK, Bendik I, Carlberg C. Scientific reports (2024).

Publication details

[6] In vivo vitamin D targets reveal the upregulation of focal adhesion-related genes in primary immune cells of healthy individuals. Ghosh Dastidar R, Jaroslawska J, Malinen M, Tuomainen TP, Virtanen JK, Bendik I, Carlberg C. Scientific reports. 2024;14(1):17552. DOI 10.1038/s41598-024-68741-9; PMID 39080417; PMCID PMC11289414.

Read more →
Source

Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial.

[7] Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial.

Publication details

[7] Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial. Berlanga-Taylor AJ, Plant K, Dahl A, Lau E, Hill M, Sims D, Heger A, Emberson J, Armitage J, Clarke R, Knight JC. EBioMedicine. 2018;31:133-142. DOI 10.1016/j.ebiom.2018.04.010; PMID 29685792; PMCID PMC6013786.

Read more →
Source

Influence of Vitamin D Status and Vitamin D3 Supplementation on Genome Wide Expression of White Blood Cells: A Randomized Double-Blind Clinical Trial

The objective of this study was to determine the effect of vitamin D status and subsequent vitamin D supplementation on broad gene expression in healthy adults.

Publication details

[8] Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial. Hossein-nezhad A, Spira A, Holick MF. PloS one. 2013;8(3):e58725. DOI 10.1371/journal.pone.0058725; PMID 23527013; PMCID PMC3604145.

Read more →